Dermatan sulfate anticoagulation: future replacement for heparin?
Gravlee
G P
GP
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D000990:Antithrombin III / Q000187:drug effects; D002315:Cardiopulmonary Bypass; D003871:Dermatan Sulfate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004357:Drug Synergism; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D015844:Heparin Cofactor II / Q000187:drug effects; D010314:Partial Thromboplastin Time; D011446:Prospective Studies; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors; D014914:Whole Blood Coagulation Time
D000925:Anticoagulants; D003871:Dermatan Sulfate; D015844:Heparin Cofactor II; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin